Search research articles
Contact Us
Filters
Showing results (81-90 of 110) with videos related to
Page
of 11
Sort By:
Journal of Medicinal Chemistry
|
May 25, 2012
Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts
Roben G Gieling, Muhammad Babur, Lupti Mamnani, et al.
Molecular Cancer Therapeutics
|
October 14, 2003
Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts
Rachel L Cowen, Adam V Patterson, Brian A Telfer, et al.
Medchemcomm
|
August 16, 2018
<i>N-tert</i>-Prenylation of the indole ring improves the cytotoxicity of a short antagonist G analogue against small cell lung cancer
Shaun C Offerman, Manikandan Kadirvel, Osama H Abusara, et al.
Molecular Cancer Therapeutics
|
October 5, 2014
Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport
Becky M Bola, Amy L Chadwick, Filippos Michopoulos, et al.
The Journal of Biological Chemistry
|
August 29, 2012
Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor
Cristina Ferreras, Graham Rushton, Claire L Cole, et al.
Oncogene
|
January 23, 2002
A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis
Kaye J Williams, Brian A Telfer, Rachel E Airley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2009
The mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) enhances the radiation responsiveness of lung and colorectal tumor xenografts
Aoife M Shannon, Brian A Telfer, Paul D Smith, et al.
Oncogene
|
May 13, 2021
The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion
Qiuping Xu, Jingwei Zhang, Brian A Telfer, et al.
Scientific Reports
|
November 16, 2018
Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters
Manal Mehibel, Fernando Ortiz-Martinez, Nadine Voelxen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2009
Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly(ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo?
Majid Ali, Brian A Telfer, Cian McCrudden, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 110) with videos related to
Sort By:
Page
of 11
Journal of Medicinal Chemistry
|
May 25, 2012
Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts
Roben G Gieling, Muhammad Babur, Lupti Mamnani, et al.
Molecular Cancer Therapeutics
|
October 14, 2003
Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts
Rachel L Cowen, Adam V Patterson, Brian A Telfer, et al.
Medchemcomm
|
August 16, 2018
<i>N-tert</i>-Prenylation of the indole ring improves the cytotoxicity of a short antagonist G analogue against small cell lung cancer
Shaun C Offerman, Manikandan Kadirvel, Osama H Abusara, et al.
Molecular Cancer Therapeutics
|
October 5, 2014
Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport
Becky M Bola, Amy L Chadwick, Filippos Michopoulos, et al.
The Journal of Biological Chemistry
|
August 29, 2012
Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor
Cristina Ferreras, Graham Rushton, Claire L Cole, et al.
Oncogene
|
January 23, 2002
A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis
Kaye J Williams, Brian A Telfer, Rachel E Airley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2009
The mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) enhances the radiation responsiveness of lung and colorectal tumor xenografts
Aoife M Shannon, Brian A Telfer, Paul D Smith, et al.
Oncogene
|
May 13, 2021
The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion
Qiuping Xu, Jingwei Zhang, Brian A Telfer, et al.
Scientific Reports
|
November 16, 2018
Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters
Manal Mehibel, Fernando Ortiz-Martinez, Nadine Voelxen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2009
Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly(ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo?
Majid Ali, Brian A Telfer, Cian McCrudden, et al.
Page
of 11